Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 0 | 0 | 200 | 1,342 | 2,071 |
| Gross Profit | N/A | N/A | 200 | 1,342 | 2,071 |
| Operating Expenses | 6,777 | 5,029 | 6,994 | 10,386 | 8,636 |
| Operating Income | -6,777 | -5,029 | -6,793 | -9,043 | -6,565 |
| Interest Expense | 4,549 | 1,503 | 921 | 1,893 | 3,119 |
| Other Income | -2,558 | 3,567 | -5,169 | -1,271 | 204 |
| Pre-tax Income | -13,883 | -2,965 | -12,883 | -12,208 | -9,481 |
| Income Tax | 2 | 3 | 4 | 2 | 2 |
| Net Income Continuous | -13,886 | -2,968 | -12,887 | -12,210 | -9,482 |
| Net Income | $-13,886 | $-2,968 | $-12,887 | $-12,210 | $-9,482 |
| EPS Basic Total Ops | -316.22 | -81.08 | -38.14 | -24.92 | -54.35 |
| EPS Basic Continuous Ops | -315.90 | -81.11 | -21.37 | -24.88 | -54.33 |
| EPS Diluted Total Ops | -318.62 | -114.41 | -38.14 | -24.92 | -54.35 |
| EPS Diluted Continuous Ops | -315.90 | -81.08 | -21.37 | -24.88 | -54.33 |
| EBITDA(a) | $-3,360 | $-4,334 | $-6,505 | $-8,022 | $-4,514 |